Oumou Bah Sow

Four Months of Rifampin or Nine Months of Isoniazid for Latent Tuberculosis in Adults

Dick Menzies, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 386 citations · Full text

Public Health, Pharmacotherapy, Antimicrobial Pharmacotherapy +16

Safety and Side Effects of Rifampin versus Isoniazid in Children

Thierno Diallo, Mênonli Adjobimey, Rovina Ruslami et al. · New England Journal of Medicine · 2018 · 162 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

A Semimechanistic Pharmacokinetic-Enzyme Turnover Model for Rifampin Autoinduction in Adult Tuberculosis Patients

Wynand Smythe, Akash Khandelwal, Corinne Merle et al. · Antimicrobial Agents and Chemotherapy · 2012 · 88 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16

A pivotal registration phase III, multicenter, randomized tuberculosis controlled trial: design issues and lessons learnt from the Gatifloxacin for TB (OFLOTUB) project

Corinne Merle, Charalambos Sismanidis, Oumou Bah Sow et al. · Trials · 2012 · 34 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +16

Aid when ‘there is nothing left to offer’: Experiences of palliative care and palliative care needs in humanitarian crises

Lisa Schwartz, Élysée Nouvet, Sonya de Laat et al. · PLOS Global Public Health · 2023 · 13 citations · Full text

Health Professions, Emergency Preparedness, Health Policy +17